CUAMC
JANX icon

China Universal Asset Management Company’s Janux Therapeutics JANX Stock Holding History

China Universal Asset Management Company’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Sell
9,706
-1,089
-10% -$15.8K 0.01% 379
2026
Q1 		$150K Buy
10,795
+994
+10% +$13.6K 0.01% 374
2025
Q4 		$135K Sell
9,801
-733
-7% -$17.2K 0.01% 386
2025
Q3 		$257K Sell
10,534
-1,351
-11% -$32.9K 0.02% 312
2025
Q2 		$275K Buy
11,885
+30
+0.3% +$790 0.03% 286
2025
Q1 		$320K Buy
11,855
+727
+7% +$27.4K 0.03% 281
2024
Q4 		$596K Buy
11,128
+1,095
+11% +$57.9K 0.06% 231
2024
Q3 		$456K Buy
10,033
+3,943
+65% +$172K 0.05% 233
2024
Q2 		$255K Sell
6,090
-3,653
-37% -$172K 0.04% 210
2024
Q1 		$367K Buy
9,743
+4,400
+82% +$95.8K 0.05% 212
2023
Q4 		$57.3K Buy
+5,343
New +$46.2K 0.01% 359
2022
Q4 		– Sell
-390
Closed -$5K – 423
2022
Q3 		$5K Buy
+390
New +$5.21K ﹤0.01% 273

Other funds holding JANX

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
S
SimplyRich Carlsbad, California $427M AUM 43.67% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return

China Universal Asset Management Company's JANX Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Janux Therapeutics (JANX) stake by 10% in Q2 2026, selling an estimated $15.8K and leaving 9,706 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #379.

China Universal Asset Management Company first reported a position in JANX in Q3 2022 and has held it in 12 quarters since. The position peaked at $596K in Q4 2024. 39 funds tracked by Wall St. Rank hold JANX as of Q2 2026.

  • China Universal Asset Management Company held 9,706 shares of Janux Therapeutics worth $149K as of Q2 2026.
  • China Universal Asset Management Company sold 1,089 Janux Therapeutics shares in Q2 2026, an estimated $15.8K.
  • Janux Therapeutics made up 0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #379 holding.
  • China Universal Asset Management Company first reported a position in Janux Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • China Universal Asset Management Company's Janux Therapeutics position peaked at $596K in Q4 2024.
  • 39 funds tracked by Wall St. Rank held Janux Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.